MYC and plasma cell myeloma: The small molecule BRD4 inhibitor JQ1 has been shown to downregulate the MYC transcriptional network and inhibit tumor growth of MYC-driven multiple myeloma [9], lymphoma [10], and neuroblastoma [11].